Original Research

Published on 23 Aug 2024

Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Wei Wang
Min Kong
Fu Shen
Ping Li
Cheng Chen
Yueqin Li
Cheng Li
Zhiqiang Qian
Aihua Zhong
Yuhua Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1434078

1,311 views

Review

Published on 23 Aug 2024

Role of UFMylation in tumorigenesis and cancer immunotherapy

in Cancer Immunity and Immunotherapy

Li-juan Ding
Xin Jiang
Te Li
Shudong Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454823

1,471 views
1 citation

Case Report

Published on 23 Aug 2024

Durable response to pembrolizumab in hepatic metastasis from colonic carcinoma with Lynch syndrome: a case report

in Cancer Immunity and Immunotherapy

Cheng Xue
Dongqing Zhu
Xin Wang
Lina Jiao
Yunhui Lu
Sanli Zhang
Jiayi Lv
Linlin Cui
Mengna Ruan
Dechao Xu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455907

1,485 views

Original Research

Published on 23 Aug 2024

HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis

in Cancer Immunity and Immunotherapy

Yan-zhu Chen
Zhi-shang Meng
Zuo-lin Xiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1415435

1,389 views

Review

Published on 23 Aug 2024

Toxicity in the era of immune checkpoint inhibitor therapy

in Cancer Immunity and Immunotherapy

Synat Keam
Naimah Turner
Fernanda G. Kugeratski
Rene Rico
Jocelynn Colunga-Minutti
Rayansh Poojary
Sayan Alekseev
Anisha B. Patel
Yuanteng Jeff Li
Ajay Sheshadri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447021

2,947 views

Original Research

Published on 23 Aug 2024

Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells

in Cancer Immunity and Immunotherapy

Sugandha Narayan
Rajdeep Dalal
Zaigham Abbas Rizvi
Amit Awasthi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1389387

1,355 views

Review

Published on 23 Aug 2024

Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects

in Cancer Immunity and Immunotherapy

Chaofan Chen
Pengfei Yuan
Zhiyun Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1446532

1,744 views

Original Research

Published on 22 Aug 2024

Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy

in Cancer Immunity and Immunotherapy

Ziang Chen
Jia Hu
Yuxi Ou
Fangdie Ye
Weijian Li
Shenghua Liu
Haowen Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1427124

1,770 views

Editorial

Published on 22 Aug 2024

Editorial: Toll-like receptor expression in transformed cells: role in tumor development and cancer therapies

in Cancer Immunity and Immunotherapy

Fabian Benencia
Laura D. Alaniz
Kelly D. McCall

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478431

521 views

Review

Published on 22 Aug 2024

Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Jie Zheng
Shuang Xu
Guoyu Wang
Yiming Shi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1434171

1,866 views

Original Research

Published on 21 Aug 2024

AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

in Cancer Immunity and Immunotherapy

Austin Rayford
Fabian Gärtner
Maria P. Ramnefjell
James B. Lorens
David R. Micklem
Marianne Aanerud
Agnete S. T. Engelsen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1444007

1,785 views

Review

Published on 21 Aug 2024

Immunotherapy for colorectal cancer

in Cancer Immunity and Immunotherapy

Bing Yu
Jian Kang
Hong Lei
Zhe Li
Hao Yang
Meng Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433315

1,871 views

Original Research

Published on 21 Aug 2024

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing

in Cancer Immunity and Immunotherapy

Ding-ming Song
Tong Shen
Kun Feng
Yi-bo He
Shi-liang Chen
Yang Zhang
Wen-fei Luo
Lu Han
Ming Tong
Yanyang Jin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419126

1,961 views

Original Research

Published on 21 Aug 2024

TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma

in Cancer Immunity and Immunotherapy

Zilong Chen
Haoxi Cai
Weiwei Ye
Junming Wu
Jing Liu
Yun Xie
Shiqiang Feng
Yuanpei Jin
Yunxia Lv
Hui Ye

Frontiers in Immunology

doi 10.3389/fimmu.2024.1445472

1,584 views

Review

Published on 21 Aug 2024

Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers

in Cancer Immunity and Immunotherapy

Ana Montero-Calle
María Garranzo-Asensio
Maria Teresa Moreno-Casbas
Susana Campuzano
Rodrigo Barderas

Frontiers in Immunology

doi 10.3389/fimmu.2024.1455602

1,535 views

Original Research

Published on 21 Aug 2024

Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity

in Cancer Immunity and Immunotherapy

Tatiana Akimova
Liqing Wang
Zhanna Bartosh
Lanette M. Christensen
Evgeniy Eruslanov
Sunil Singhal
Veenu Aishwarya
Wayne W. Hancock

Frontiers in Immunology

doi 10.3389/fimmu.2024.1426657

1,395 views

Navigation group

Articles

Ginsenoside Rg3 targets glycosylation of PD-L1 to enhance anti-tumor immunity in non-small cell lung cancer

Role of UFMylation in tumorigenesis and cancer immunotherapy

Durable response to pembrolizumab in hepatic metastasis from colonic carcinoma with Lynch syndrome: a case report

HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis

Toxicity in the era of immune checkpoint inhibitor therapy

Zinc dampens antitumor immunity by promoting Foxp3+ regulatory T cells

Nanomedicine-based cancer immunotherapy: a bibliometric analysis of research progress and prospects

Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy

Editorial: Toll-like receptor expression in transformed cells: role in tumor development and cancer therapies

Applications of CT-based radiomics for the prediction of immune checkpoint markers and immunotherapeutic outcomes in non-small cell lung cancer

AXL expression reflects tumor-immune cell dynamics impacting outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitor monotherapy

Immunotherapy for colorectal cancer

LIG1 is a novel marker for bladder cancer prognosis: evidence based on experimental studies, machine learning and single-cell sequencing

TP63 transcriptionally regulates SLC7A5 to suppress ferroptosis in head and neck squamous cell carcinoma

Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers

Antisense targeting of FOXP3+ Tregs to boost anti-tumor immunity